Combination of Anti-PD-1 Antibody and Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma

Clinical trial NCT04413734 · UNKNOWN

Trial details

NCT number: NCT04413734
Sponsor: Zhejiang University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Intrahepatic Cholangiocarcinoma by AJCC V8 Stage

Start date: 2020-04-22
Primary completion: 2022-04-22
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.